{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:31:06Z","timestamp":1793784666276,"version":"4.6.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbrc.2026.154715","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:10:29Z","timestamp":1791501029000},"page":"154715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting neurohormonal signaling cascades in cardiac hypertrophy: Multi-layered anti-hypertrophic paradigm of pyrogallol"],"prefix":"10.1016","volume":"839","author":[{"given":"Gopinath","family":"Nagaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elangovan","family":"Vellaichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154715_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1469-7793.2000.00189.x","article-title":"Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium","volume":"529","author":"Petroff","year":"2000","journal-title":"J. Physiol"},{"key":"10.1016\/j.bbrc.2026.154715_bib2","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cells11213336","article-title":"Angiotensin II-Induced signal transduction mechanisms for cardiac hypertrophy","volume":"11","author":"Bhullar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154715_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.35.6.1183","article-title":"Angiotensin II and the heart: on the intracrine renin-angiotensin system","volume":"35","author":"De Mello","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2026.154715_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.bbrc.2026.154715_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5551\/jat.27292","article-title":"Angiotensin \u2161 Activates MCa-1 and Induces Cardiac Hypectrophy hnd Dysfunction dia Toll-like Reteptor 4","volume":"22","author":"Matsuda","year":"2015","journal-title":"r Atheroscler Thromb"},{"key":"10.1016\/j.bbrc.2026.154715_bib6","doi-asserted-by":"crossref","first-page":"H1027","DOI":"10.1152\/ajpheart.00697.2018","article-title":"Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways","volume":"316","author":"Singh","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2026.154715_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/cimb47070501","article-title":"Angiotensin II and cardiovascular disease: balancing pathogenic and protective pathways","volume":"47","author":"Bayraktutan","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154715_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drudis.2010.11.016","article-title":"Angiotensin II receptors and drug discovery in cardiovascular disease","volume":"16","author":"Dasgupta","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2026.154715_bib9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.120.11941","article-title":"Angiotensin II type 2 receptor: a target for protection against hypertension, metabolic dysfunction, and organ remodeling","volume":"77","author":"Fatima","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2026.154715_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154715_bib11","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bbrc.2026.154715_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1080285","article-title":"Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154715_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.107.102152","article-title":"Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy","volume":"51","author":"Sriramula","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2026.154715_bib14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/cdd.2014.46","article-title":"ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation","volume":"21","author":"Huang","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2026.154715_bib15","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/JME-16-0086","article-title":"The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy","volume":"57","author":"Zhou","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154715_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s42238-025-00332-5","article-title":"The effects of cannabidiol on nitric oxide synthases: a narrative review on therapeutic implications for inflammation and oxidative stress in health and disease","volume":"7","author":"Hooshmand","year":"2025","journal-title":"J Cannabis Res"},{"key":"10.1016\/j.bbrc.2026.154715_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2018.09.009","article-title":"Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse","volume":"124","author":"Diaz","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154715_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s11033-019-05222-7","article-title":"Steroidogenic acute regulatory protein\/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy","volume":"47","author":"Zhang","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2026.154715_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/cvr\/cvu258","article-title":"Optogenetic release of norepinephrine from cardiac sympathetic neurons alters mechanical and electrical function","volume":"105","author":"Wengrowski","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154715_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/FJC.0000000000001324","article-title":"Subcellular \u03b2-Adrenergic receptor signaling in cardiac physiology and disease","volume":"80","author":"Wei","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154715_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.31083\/j.rcm2409264","article-title":"Status of \u03b21-Adrenoceptor signal transduction System in cardiac hypertrophy and heart failure","volume":"24","author":"Dhalla","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.154715_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48167","article-title":"Golgi localized \u03b21-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLC\u03b5 to regulate cardiac hypertrophy","volume":"8","author":"Nash","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.bbrc.2026.154715_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/cvr\/cvab008","article-title":"Physiological and pathological roles of protein kinase A in the heart","volume":"118","author":"Liu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154715_bib24","doi-asserted-by":"crossref","first-page":"H725","DOI":"10.1152\/ajpheart.00621.2020","article-title":"Cardiac \u03b11A-adrenergic receptors: emerging protective roles in cardiovascular diseases","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2026.154715_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110488","article-title":"The differential involvement of \u03b11-Adrenoceptor subtypes in the molecular effects of antidepressant drugs","volume":"26","author":"Nalepa","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154715_bib26","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.cellsig.2015.06.009","article-title":"The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications","volume":"27","author":"Cotecchia","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154715_bib27","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.3892\/mmr.2015.3316","article-title":"\u03b2-Adrenergic stimulation activates protein kinase C\u03b5 and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.154715_bib28","doi-asserted-by":"crossref","first-page":"14220","DOI":"10.3390\/ijms150814220","article-title":"Functional cross-talk between the \u03b11- and \u03b21-adrenergic receptors modulates the rapidly activating delayed rectifier potassium current in Guinea pig ventricular myocytes","volume":"15","author":"Xu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154715_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa7677","article-title":"The Golgi apparatus is a functionally distinct Ca2+ store regulated by the PKA and Epac branches of the \u03b21-adrenergic signaling pathway","volume":"8","author":"Yang","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2026.154715_bib30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/biom14101334","article-title":"Potential roles of IP3 receptors and calcium in programmed cell death and implications in cardiovascular diseases","volume":"14","author":"Piamsiri","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.154715_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaf6029","article-title":"IP3 receptors: take four IP3 to open","volume":"9","author":"Taylor","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2026.154715_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fphar.2014.00035","article-title":"Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches","volume":"5","author":"Hohendanner","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154715_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tox.2007.03.018","article-title":"Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via cell cycle arrest of G2 phase and apoptosis","volume":"235","author":"Park","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2026.154715_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tips.2022.11.003","article-title":"Non-canonical Golgi-compartmentalized G\u03b2\u03b3 signaling: mechanisms, functions, and therapeutic targets","volume":"44","author":"Xu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.154715_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00395-018-0688-8","article-title":"Physiological and unappreciated roles of CaMKII in the heart","volume":"113","author":"Beckendorf","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154715_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/bit.70115","article-title":"A comprehensive review of pyrogallol: from fundamental chemistry to advanced applications and toxicological insights","volume":"123","author":"Park","year":"2026","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bbrc.2026.154715_bib37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/antiox9080732","article-title":"Comparison of in vitro and in vivo antioxidant activities of six flavonoids with similar structures","volume":"9","author":"Zeng","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.154715_bib38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jes.2021.08.011","article-title":"Unravelling the effects of complexation of transition metal ions on the hydroxylation of catechol over the whole pH region","volume":"115","author":"An","year":"2022","journal-title":"J. Environ. Sci. (China)"},{"key":"10.1016\/j.bbrc.2026.154715_bib39","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1039\/D3TB00312D","article-title":"Synthesis of biologically derived poly(pyrogallol) nanofibers for antibacterial applications","volume":"11","author":"Tian","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbrc.2026.154715_bib40","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.intimp.2008.08.001","article-title":"Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells","volume":"8","author":"Nicolis","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.154715_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.888892","article-title":"Recognition of gallotannins and the physiological activities: from chemical view","volume":"9","author":"He","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bbrc.2026.154715_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cbi.2009.11.028","article-title":"Pyrogallol-mediated toxicity and natural antioxidants: triumphs and pitfalls of preclinical findings and their translational limitations","volume":"183","author":"Upadhyay","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2026.154715_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1358\/mf.2002.24.8.705070","article-title":"Pyrogallol-induced hepatotoxicity in rats: a model to evaluate antioxidant hepatoprotective agents","volume":"24","author":"Gupta","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.bbrc.2026.154715_bib44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/15569527.2012.746358","article-title":"Pyrogallol-associated dermal toxicity and carcinogenicity in F344\/N rats and B6C3F1\/N mice","volume":"32","author":"Mercado-Feliciano","year":"2013","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154715_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jcp.10368","article-title":"Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in Guinea pig myocytes","volume":"197","author":"Malan","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2026.154715_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1385\/CT:4:4:375","article-title":"The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway","volume":"4","author":"Esberg","year":"2004","journal-title":"Cardiovasc. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2026.154715_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1011038531656","article-title":"Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart","volume":"219","author":"Sharma","year":"2001","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.154715_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2025.100667","article-title":"Brazilin-enriched Caesalpinia sappan heartwood extract mitigates Doxorubicin-induced cardiotoxicity","volume":"16","author":"Singaravel","year":"2025","journal-title":"Pharmacological Research-Modern Chinese Medicine"},{"key":"10.1016\/j.bbrc.2026.154715_bib49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/ol.2017.6185","article-title":"MAPK inhibitors enhance cell death in pyrogallol-treated human pulmonary fibroblast cells via increasing O2\u2022- levels","volume":"14","author":"Han","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2026.154715_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.fct.2009.10.010","article-title":"The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione","volume":"48","author":"Han","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2026.154715_bib51","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2026.154715_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111410","article-title":"Implications of \u03b2-Arrestin biased signaling by angiotensin II type 1 receptor for cardiovascular drug discovery and therapeutics","volume":"124","author":"Singh","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154715_bib53","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3390\/cells13232001","article-title":"Pathophysiology of Angiotensin II-Mediated hypertension, cardiac hypertrophy, and failure: a perspective from macrophages","volume":"13","author":"Carter","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154715_bib54","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.3390\/ijms23158582","article-title":"The role of PKC-MAPK signalling pathways in the development of hyperglycemia-induced cardiovascular complications","volume":"23","author":"Jubaidi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154715_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ame2.12496","article-title":"Isoproterenol mechanisms in inducing myocardial fibrosis and its application as an experimental model for the evaluation of therapeutic potential of phytochemicals and pharmaceuticals","volume":"8","author":"Bader Eddin","year":"2025","journal-title":"Animal Model. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.154715_bib56","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1074\/jbc.M116.771394","article-title":"Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization","volume":"292","author":"Chang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154715_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11357-011-9207-7","article-title":"Mechanism of Ang II involvement in activation of NF-\u03baB through phosphorylation of p65 during aging","volume":"34","author":"Kim","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.bbrc.2026.154715_bib58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.87.9.731","article-title":"Calcineurin and beyond: cardiac hypertrophic signaling","volume":"87","author":"Molkentin","year":"2000","journal-title":"Circ. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26014816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26014816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:04:11Z","timestamp":1793783051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26014816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":58,"alternative-id":["S0006291X26014816"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154715","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting neurohormonal signaling cascades in cardiac hypertrophy: Multi-layered anti-hypertrophic paradigm of pyrogallol","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154715"}}